Cyclerion Therapeutics
(NASDAQ) CYCN
Cyclerion Therapeutics Financials at a Glance
Market Cap
$6.08M
Revenue (TTM)
$2.85M
Net Income (TTM)
$2.20M
EPS (TTM)
$-0.76
P/E Ratio
-2.04
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Price
$1.57
Volume
30,691.989
Open
$1.52
Price
$1.57
Volume
30,691.989
Open
$1.52
Previous Close
$1.55
Daily Range
$1.45 - $1.52
52-Week Range
$1.03 - $3.79
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Price
$1.57
Volume
30,691.989
Open
$1.52
Previous Close
$1.55
Daily Range
$1.45 - $1.52
52-Week Range
$1.03 - $3.79
CYCN News
CYCN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cyclerion Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
1
CEO
Regina Graul, PhD
Website
www.cyclerion.comHeadquarters
Cambridge, MA 02142, US
CYCN Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-1%
Net Income Margin
-77%
Return on Equity
-25%
Return on Capital
-38%
Return on Assets
-21%
Earnings Yield
-49.02%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$6.08M
Shares Outstanding
3.93M
Volume
30.69K
Short Interest
0.00%
Avg. Volume
1.51M
Financials (TTM)
Gross Profit
$2.00M
Operating Income
$3.63M
EBITDA
$3.63M
Operating Cash Flow
$4.33M
Capital Expenditure
$0.00
Free Cash Flow
$4.33M
Cash & ST Invst.
$3.23M
Total Debt
$0.00
Cyclerion Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$875.00K
+351.0%
Gross Profit
$875.00K
+351.0%
Gross Margin
100.00%
N/A
Market Cap
$6.08M
N/A
Market Cap/Employee
$6.08M
N/A
Employees
1
N/A
Net Income
$976.00K
-35.0%
EBITDA
$976.00K
+13.5%
Quarterly Fundamentals
Net Cash
$4.57M
+59.1%
Accounts Receivable
$100.00K
+127.3%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-21.11%
N/A
Return on Invested Capital
-38.09%
N/A
Free Cash Flow
$264.00K
+84.6%
Operating Cash Flow
$264.00K
+84.6%